Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced the initiation of a Phase 2 ...
Adults with attention-deficit/hyperactivity disorder, or ADHD, who use an extended-release medication are more likely to continue the treatment and have a lower risk of developing substance use ...
The presentation will share information about etmsohio.com, the website for a free and confidential treatment program for honorably discharged veterans, as well a past or present law enforcement, ...